HPM Partners »

Ultragenyx Pharmaceutical shares owned by HPM Partners

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by HPM Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8M 32k 55.55

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Spdr S&p 500 Etf Tr Etf (SPY)
Procter And Gamble Stock (PG)
NVIDIA Corporation (NVDA)
Ishares Tr Etf (IVV)
Vanguard Tax-managed Fds Stock (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Eli Lilly & Co Stock (LLY)
Ishares Tr Stock (AGG)
Ishares Tr Stock (QUAL)
Alphabet Stock (GOOGL)
Facebook Inc cl a (META)

View all positions for HPM Partners

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
BlackRock
Sands Capital Management
T. Rowe Price Associates
State Street Corporation
ClearBridge Advisors
Federated Investors
Suvretta Capital Management
Rock Springs Capital Management
Deutsche Bank Aktiengesellschaft
Invesco
Baker Bros. Advisors
Geode Capital Management
Alliancebernstein

View all funds holding Ultragenyx Pharmaceutical